Oruka Therapeutics (ORKA) Current Leases (2024 - 2026)
Oruka Therapeutics' (ORKA) quarterly Current Leases came in at $680000.0 in Q1 2026, up 140.28% year-on-year from $283000.0 in Q1 2025, and up 9.85% quarter-over-quarter from $619000.0 in Q4 2025.
Oruka Therapeutics (ORKA) Current Leases (2024 - 2026) Analysis & Trends
Oruka Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $680000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 140.28% year-over-year to $680000.0 in Q1 2026; TTM through Mar 2026 was $680000.0, a 140.28% increase from a year earlier, with the FY2025 full-year figure at $619000.0, up 190.61% from the prior year.
- Current Leases rose to $680000.0 in Q1 2026 per ORKA's latest filing, from $619000.0 in the prior quarter.
- Across five years, Current Leases topped out at $680000.0 in Q1 2026 and bottomed at $146000.0 in Q3 2024.
- The 3-year median for Current Leases is $419000.0 (2025), against an average of $431428.6.
- Across the five-year window, Current Leases soared 190.61% in 2025 and surged 140.28% in 2026, its largest moves.
- Year by year, Current Leases stood at $213000.0 in 2024, then surged by 190.61% to $619000.0 in 2025, then grew by 9.85% to $680000.0 in 2026.
- Per Business Quant, the three latest ORKA Current Leases figures stand at $680000.0 (Q1 2026), $619000.0 (Q4 2025), and $419000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | 680,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 680,000.00 |
| Dec 31, 2025 | 619,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 660,000.00 |
| Mar 31, 2025 | 283,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 146,000.00 |